1. |
Ma RW, Chapman K.A systematic review of the effect of diet in prostate cancer prevention and treatment.J Hum Nutr Diet, 2009, 22(3):187-199.
|
2. |
Bratt O.Hereditary prostate cancer:clinical aspects.J Urol, 2002, 168(3):906-913.
|
3. |
Meyer F, Bairati I, Shadmani R, et al.Dietary fat and prostate cancer survival.Cancer Causes Control, 1999, 10(4):245-251.
|
4. |
Hsing AW, Chokkalingam AP.Prostate cancer epidemiology.Front Biosci, 2006, 11(5):1388-1413.
|
5. |
Jemal A, Bray F, Center MM, et al.Global cancer statistics.CA Cancer J Clin, 2011, 61(2):134.
|
6. |
赵平, 陈万青.中国肿瘤登记年报.北京:中国协和医科大学, 2004.
|
7. |
李鸣, 张思维, 马建辉, 等.中国部分市前列腺癌发病趋势比较研究.中华泌尿外科杂志, 2009, 30(6):567-570.
|
8. |
Hammarsten J, Hogstedt B.Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high stage and high grade clinical prostate cancer.Blood Pressure, 2004, 13(1):47-455.
|
9. |
Hammarsten J, Högstedt B.Hyperinsulinaemia:a prospective risk factor for lethal clinical prostate cancer.Eur J Cancer, 2005, 41(18):2887-2895.
|
10. |
Mittal A, Sathian B, Chandrasekharan N, et al.Role of hypercholesterolemia in prostate cancer-case control study from Manipal Teaching Hospital Pokhara, Nepal.Asian Pac J Cancer Prev, 2011, 12(8):1905-1907.
|
11. |
Bielecka-Dbrowa A, Hannam S, Rysz J, et al.Malignancy-associated dyslipidemia.Open Cardiovasc Med J, 2011, 5(1):35-40.
|
12. |
Freeman MR, Solomon KR.Cholesterol and prostate cancer.J Cell Biochem, 2004, 91(1):54-69.
|
13. |
di Vizio D, Solomon KR, Freeman MR.Cholesterol and cholesterolrich membranes in prostate cancer:an update.Tumori, 2008, 94(5):633-639.
|
14. |
Shannon J, Tewoderos S, Garzotto M, et al.Statins and prostate cancer risk:a case-control study.Am J Epidemiol, 2005, 162(4):318-325.
|
15. |
Hamilton RJ, Banez LL, Aronson WJ, et al.Statin medication use and the risk of biochemical recurrence after radical prostatectomy:results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.Cancer, 2010, 116(14):3389-3398.
|